KCCure - Kidney Cancer Research Alliance

KCCure - Kidney Cancer Research Alliance Kidney Cancer Cure is a grassroots organization dedicated to funding research to find a cure for kidney cancer. KCCure is a Virginia registered tax exempt 501c3 organization.
(15)

Our EIN number is 81-2067843

Our EIN number is 81-2067843

Operating as usual

To the amazing members of our kidney cancer communities, we are grateful for the love and support that you give to one a...
02/14/2021

To the amazing members of our kidney cancer communities, we are grateful for the love and support that you give to one another. May your day be filled with hope and love.

Today, we honor all of the members of our #kidneycancer communities as well as patients and families around the world wh...
02/04/2021

Today, we honor all of the members of our #kidneycancer communities as well as patients and families around the world who have been impacted by cancer. No one fights alone!

Thanks to all of the patients who participated in our latest survey!  The results show that most patients remain anxious...
01/25/2021
COVID-19 Vaccine - Kidney Cancer Patient Survey - KCCure

Thanks to all of the patients who participated in our latest survey! The results show that most patients remain anxious about COVID-19. Most patients are willing to get vaccinated. However, there is still uncertainty related to safety and concerns about how the vaccine will impact cancer treatment. See the full results at KCCure.

COVID-19 vaccine - kidney cancer patient survey. Results from a survey of over 500 patients related to anxiety and concerns regarding COVID-19 vaccines.

The U.S. FDA has approved Cabometyx (cabozatinib) in combination with Opdivo (nivolumab) for first line treatment of adv...
01/22/2021
Exelixis Announces U.S. FDA Approval of CABOMETYX® (cabozantinib) in Combination with OPDIVO® (nivolumab) as a First-Line Treatment for Patients with Advanced Renal Cell Carcinoma | Exelixis, Inc.

The U.S. FDA has approved Cabometyx (cabozatinib) in combination with Opdivo (nivolumab) for first line treatment of advanced renal cell carcinoma. This is a the fourth combination therapy to be approved in this setting. New treatments mean new hope for patients living with this disease. Our thanks to the patients, doctors and researchers who helped make this possible.

The Investor Relations website contains information about Exelixis, Inc.'s business for stockholders, potential investors, and financial analysts.

Connecting with others is a crucial part of survivorship for people impacted by #kidneycancer. KCCure runs eight unique ...
01/18/2021
Kidney Cancer Patient Support Communities - KCCure

Connecting with others is a crucial part of survivorship for people impacted by #kidneycancer. KCCure runs eight unique private communities for kidney cancer patients and caregivers. Learn more about our groups as well as other existing support communities at KCCure.

Connecting with others is an important part of survivorship for kidney cancer patients. Learn more about communities for you here at KCCure!

If you haven't yet taken our survey on kidney cancer patient views related to COVID-19 and the vaccine roll-out, this is...
01/15/2021
COVID-19 - Kidney Cancer Patients

If you haven't yet taken our survey on kidney cancer patient views related to COVID-19 and the vaccine roll-out, this is the final weekend to participate. Help us reach 500 and make the voice of kidney cancer patients heard!

Take this survey and help share the voice of kidney cancer patients!

KCCure statement on Cantata Trial results: We applaud the brave #kidneycancer patients willing to enroll in this trial t...
01/05/2021
Cantata Trial Fails to Show Benefit in RCC - KCCure

KCCure statement on Cantata Trial results: We applaud the brave #kidneycancer patients willing to enroll in this trial to advance the field forward. These aren't the results that we all hoped for - but new knowledge benefits us all.

Results from the phase 2 Cantata trial in RCC found that adding the glutanimase inhibitor telaglenastat to cabozantinib did not improve PFS for patients.

Help make the patient voice heard! Our COVID-19 survey is open for one more week. Let providers know your views on how t...
01/03/2021
COVID-19 - Kidney Cancer Patients

Help make the patient voice heard! Our COVID-19 survey is open for one more week. Let providers know your views on how the pandemic is impacting your care and share your thoughts about getting vaccinated.

Take this survey and help share the voice of kidney cancer patients!

Happy New Year! As we say goodbye to the challenges of 2020 - we look ahead to a new year with hope and optimism. Celebr...
12/31/2020

Happy New Year! As we say goodbye to the challenges of 2020 - we look ahead to a new year with hope and optimism. Celebrate with us by sharing your achievements of last year and your goals for the new year!

12/30/2020

More than 150,000 people die worldwide from kidney cancer every year. This video represents just a fraction of the toll that this disease has taken. Please take a moment to honor and remember those that we lost this year.

May your hearts and homes be filled with joy and love today and always. Merry Christmas from KCCure.
12/25/2020

May your hearts and homes be filled with joy and love today and always. Merry Christmas from KCCure.

12 Day Challenge - Day 12! We hope everyone has enjoyed the 12 day challenge as much as we have. For the final day - tak...
12/24/2020

12 Day Challenge - Day 12! We hope everyone has enjoyed the 12 day challenge as much as we have. For the final day - take a look back at each of the days - doves, swans, dancers... Tell us your favorite image! Let's see which one gets the most votes.

12 Day Challenge - Day 11: KCCure is dedicated to making sure your voice is heard! We're doing a short survey to educate...
12/23/2020

12 Day Challenge - Day 11: KCCure is dedicated to making sure your voice is heard! We're doing a short survey to educate doctors about patient views related to kidney cancer and the COVID-19 vaccine. For today's challenge, share your views by taking our survey. Be sure to comment on today's post to be entered in our drawing! https://www.surveymonkey.com/r/KCCure-COVID

12 Day Challenge - Day 9: We are grateful to the many doctors and researchers dedicating their lives to the "cancer moon...
12/21/2020

12 Day Challenge - Day 9: We are grateful to the many doctors and researchers dedicating their lives to the "cancer moonshot." For today's challenge - give a shout out to the doctor or doctors who have made a difference for you!

12 Day Challenge - Day 8: In today's post, we've hidden kidney's throughout the image. How many can you find? Post your ...
12/20/2020

12 Day Challenge - Day 8: In today's post, we've hidden kidney's throughout the image. How many can you find? Post your answer in the comments below to be entered in today's drawing!

12 Day Challenge - Day 7: Research shows that having a pet can improve health in many ways - including reducing anxiety ...
12/19/2020

12 Day Challenge - Day 7: Research shows that having a pet can improve health in many ways - including reducing anxiety and relieving stress. For today's challenge, post a picture of your furry friend and share how they helped you. Participants will be entered in today's drawing for KCCure prizes!

12 Day Challenge - Day 6: Yesterday's 5 for 5 challenge raised over $1,000 for kidney cancer research. For today's chall...
12/18/2020

12 Day Challenge - Day 6: Yesterday's 5 for 5 challenge raised over $1,000 for kidney cancer research. For today's challenge, help us say thank you. In the comment section, tell our supporters why research is so important to you.

12 Day Challenge - Day 5: Did you know that our research grant program is funded almost entirely by donations ranging fr...
12/17/2020

12 Day Challenge - Day 5: Did you know that our research grant program is funded almost entirely by donations ranging from $5 to $50? For today's challenge, launch a $25 Facebook fundraiser for KCCure. Ask 5 of your friends to give $5. Let's see how much research we can fund in one day! https://www.facebook.com/fund/kccure/

12 Day Challenge – Day 4: Kidney Cancer is a rare disease, and it can be difficult to raise awareness. For today’s chall...
12/16/2020

12 Day Challenge – Day 4: Kidney Cancer is a rare disease, and it can be difficult to raise awareness. For today’s challenge – share a picture of your tattoo, a kidney cancer t-shirt or your favorite ribbon (orange or green? we love them both!). Let’s show the world how we’re all working together to make the kidney cancer patient voice heard!

12 Day Challenge - Day 3: Our patient education resources are designed to answer the questions that are most frequently ...
12/15/2020

12 Day Challenge - Day 3: Our patient education resources are designed to answer the questions that are most frequently asked in our communities. To be entered into today’s drawing, post an answer to this question: Jim had a 4.6 cm renal mass removed. The pathology report revealed clear cell RCC with microscopic invasion into the branches of the renal vein. There is no evidence of disease outside the kidney. What stage is his kidney cancer? hint - check out our staging guide for the answer! https://kccure.org/kidney-cancer-staging/

12 Day Challenge - Day 2! It might seem like a small thing – but did you know that “liking” our page can help us increas...
12/14/2020

12 Day Challenge - Day 2! It might seem like a small thing – but did you know that “liking” our page can help us increase awareness about kidney cancer? Not only will it help you stay connected with KCCure – it can also increase our visibility for others who are newly diagnosis. Be sure to let us know in the comment section that you liked our page (or that you’re already a fan) to be entered in today’s drawing.

12 Day Challenge! Everyone with a diagnosis remembers the day they first heard the words: kidney cancer. But many people...
12/13/2020

12 Day Challenge! Everyone with a diagnosis remembers the day they first heard the words: kidney cancer. But many people also remember the moment they joined a kidney cancer patient community and learned that they weren’t alone. Who was the person that you connected with? In the comments below - give a shout out to the person that made a difference for you!

Let’s be honest, 2020 has been challenging and we’re all ready to welcome 2021. Help us kick off the countdown with a 12...
12/12/2020

Let’s be honest, 2020 has been challenging and we’re all ready to welcome 2021. Help us kick off the countdown with a 12 Days of Christmas Challenge. Each day we’ll be posting a new activity or action you can take to support our mission. Even better? Those who participate will be entered into a daily drawing to win fun KCCure prizes.

May peace, love, and joy come to you during the festival of lights.
12/10/2020

May peace, love, and joy come to you during the festival of lights.

What matters to patients when selecting treatment for advanced #kidneycancer? Hear what over 1,000 patients had to say! ...
12/07/2020

What matters to patients when selecting treatment for advanced #kidneycancer? Hear what over 1,000 patients had to say! KCCure is dedicated to making sure that the patient voice is heard when it comes to research.

Thank you to everyone who made #GivingTuesday such a success. We are grateful for your generosity and overwhelming suppo...
12/02/2020

Thank you to everyone who made #GivingTuesday such a success. We are grateful for your generosity and overwhelming support for #kidneycancer patients!

Today is #GivingTuesday! We know that the needs of our kidney cancer patient communities are unique and diverse. That's ...
12/01/2020
Support Kidney Cancer Research - KCCure

Today is #GivingTuesday! We know that the needs of our kidney cancer patient communities are unique and diverse. That's why we have created ways for you to support research that is meaningful to you. Help us find the cures that we need - Support Research Today!

Support kidney cancer research that is meaningful to you! Select from multiple funds that are driving research toward needed gaps in care.

1.)We are thankful for the health care providers fighting to treat kidney cancer and find a cure. 2.)We are thankful for...
11/26/2020

1.)We are thankful for the health care providers fighting to treat kidney cancer and find a cure. 2.)We are thankful for the medical advances that have occurred this year giving us new hope. 3.)We are thankful for the 5,000+ members of our #kidneycancer patient communities who support and empower one another everyday. From all of us at KCCure - Happy Thanksgiving!

Here's a little Thanksgiving fun - can you spot the kidneys hidden in this picture? Tell us how many you can find!
11/25/2020

Here's a little Thanksgiving fun - can you spot the kidneys hidden in this picture? Tell us how many you can find!

When Rich was recovering from surgery for #kidneycancer - his dog knew something was wrong and wouldn't leave is side. R...
11/12/2020

When Rich was recovering from surgery for #kidneycancer - his dog knew something was wrong and wouldn't leave is side. Research shows that pets have the power to help us heal from emotional and physical pain. Do you have a pet who helped you? Share your photos with KCCure!

Happy Veteran's Day from KCCure. We are grateful for your service!
11/11/2020

Happy Veteran's Day from KCCure. We are grateful for your service!

Good news for advanced kidney cancer patients! More treatments mean more options. Thanks to the brave patients who parti...
11/10/2020
KEYTRUDA® (pembrolizumab) Plus LENVIMA® (lenvatinib) Demonstrated Statistically Significant Improvement in Progression-Free Survival (PFS), Overall Survival (OS) and Objective Response Rate (ORR) Versus Sunitinib as First-Line Treatment for Patient

Good news for advanced kidney cancer patients! More treatments mean more options. Thanks to the brave patients who participated in this trial to make this data available. We look forward to seeing the full results from the CLEAR study!

KEYTRUDA Plus LENVIMA Demonstrated Statistically Significant Improvement Versus Sunitinib as First-Line Treatment for Patients With Advanced RCC

Happy Birthday to KCCure Treasurer Vicki Loucks! After losing her husband to kidney cancer, Vicki remained devoted to ma...
10/12/2020

Happy Birthday to KCCure Treasurer Vicki Loucks! After losing her husband to kidney cancer, Vicki remained devoted to making a difference for others. Take a moment to wish her happy birthday and say thanks for all that she does to make the world a brighter place!

Want to help fund kidney cancer research every time you shop? Follow these simple instructions to sign up for AmazonSmil...
10/08/2020

Want to help fund kidney cancer research every time you shop? Follow these simple instructions to sign up for AmazonSmile and start making a difference today!

Address

673 Potomac Station Drive #636
Leesburg, VA
20176

Alerts

Be the first to know and let us send you an email when KCCure - Kidney Cancer Research Alliance posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.

Contact The Business

Send a message to KCCure - Kidney Cancer Research Alliance:

Videos

KCCure - curing kidney cancer together

Kidney Cancer Research Alliance (KCCure) is a grassroots organization of patients, caregivers, doctors and medical researchers dedicated to finding a cure for kidney cancer.

We seek to increase and accelerate research through a one-of-a-kind peer reviewed research grant program. In addition, we provide answers to patients and caregivers seeking information about their diagnosis and connect patients to one another so they can be part of a community of hope.

KCCure is not one story - but many stories. We are doctors and patients committed to ending kidney cancer.

Nearby non profit organizations


Other Nonprofit Organizations in Leesburg

Show All

Comments

Our first multi-speaker online symposium with partner Moffitt Cancer Center - Tampa. Register now at: bit.ly/JNF2021
Our first multi-speaker online symposium with partner Moffitt Cancer Center - Tampa. Register now at: bit.ly/JNF2021
Rare variations can often teach us about the more common conditions. Be sure to register for this talk at: https://www.jnfkidneycancer.org/new-events/2020/11/11/rare-kc-renal-medullary-carcinoma
You can learn from this talk whether your are impacted by a rare form or not. Register here: https://www.jnfkidneycancer.org/new-events/2020/11/11/rare-kc-renal-medullary-carcinoma
Rare variations can often teach us about the more common conditions. Be sure to register for this talk at: https://www.jnfkidneycancer.org/new-events/2020/11/11/rare-kc-renal-medullary-carcinoma
Dr. Msaouel's talk will emphasize rare kidney cancer variants such as renal medullary carcinoma. Register now at: https://www.jnfkidneycancer.org/new-events/2020/11/11/rare-kc-renal-medullary-carcinoma
This Wednesday get some insight into the future of your treatment. Register here: https://www.jnfkidneycancer.org/new-events/2020/11/11/kc-concerns-during-treatment